Bovilis Bovipast RSP

An aqueous suspension for subcutaneous injection. One dose (5 ml) of the vaccine contains at least 105.5 TCID50 inactivated BRS virus (strain EV 908) and at least 107.3 TCID50 Parainfluenza 3 virus (strain SF-4 Reisinger), together with 9 x 109 cells inactivated Mannheimia haemolytica bacteria (serotype A1) propagated under conditions of iron restriction. Aluminium hydroxide and Quil A are included as adjuvants. Sodium timerfonate is included as a preservative.

Product information for Veterinary Healthcare Professionals

For the active immunisation of cattle against
– Parainfluenza3 virus (PI3 virus), to reduce infections.
– Bovine Respiratory Syncytial Virus (BRSV) to reduce infection and clinical signs.
– Mannheimia haemolytica serotype A1, to reduce infection, mortality, clinical signs, lung lesions and bacterial invasion of the lung caused by serotypes A1 and A6.

For uses, dosage, contra-indications and warnings please consult your prescriber or the Summary of Product Characteristics (SPC). Further information is available on request. Use medicines responsibly. 

Legal category


Packaging Quantities

50 ml bottle (10 doses) 

Summary of Product Characteristics

For Summary of Product Characteristics, first click on this link. Then type in Bovilis Bovipast in Product name field. Click on Run search. Subsequently click on View SPC on line listing opposite Bovilis Bovipast.